10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
22.62
-0.52 (-2.25%)
Mar 3, 2026, 4:00 PM EST - Market closed
10x Genomics Market Cap
10x Genomics has a market cap or net worth of $2.89 billion as of March 4, 2026. Its market cap has increased by 97.89% in one year.
Market Cap
2.89B
Enterprise Value
2.45B
1-Year Change
97.89%
Ranking
Category
Stock Price
$22.62
Market Cap Chart
Since September 12, 2019, 10x Genomics's market cap has decreased from $4.95B to $2.89B, a decrease of -41.63%. That is a compound annual growth rate of -7.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 2.96B | 43.22% |
| Dec 31, 2025 | 2.06B | 18.74% |
| Dec 31, 2024 | 1.74B | -73.72% |
| Dec 29, 2023 | 6.61B | 58.59% |
| Dec 30, 2022 | 4.17B | -74.93% |
| Dec 31, 2021 | 16.64B | 9.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tempus AI | 9.09B |
| BrightSpring Health Services | 8.44B |
| HealthEquity | 6.54B |
| Waystar Holding | 4.89B |
| Doximity | 4.47B |
| Hinge Health | 3.38B |
| Privia Health Group | 2.94B |
| HeartFlow | 1.95B |